Candriam S.C.A. - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$13,051,075
-1.4%
139,375
-6.1%
0.09%
-4.2%
Q2 2023$13,242,469
-46.4%
148,375
-40.7%
0.10%
-43.9%
Q1 2023$24,709,105
+6.3%
250,375
+31.5%
0.17%
+8.9%
Q4 2022$23,249,409
+9.1%
190,375
-7.8%
0.16%
+4.7%
Q3 2022$21,311,000
+3.9%
206,375
-6.5%
0.15%
-11.2%
Q2 2022$20,520,000
+6.4%
220,751
+34.3%
0.17%
+29.0%
Q1 2022$19,283,000
-39.9%
164,318
-31.1%
0.13%
-36.1%
Q4 2021$32,075,000
-19.6%
238,422
-4.8%
0.20%
-24.4%
Q3 2021$39,909,000
+7.2%
250,399
-11.5%
0.27%
+6.3%
Q2 2021$37,226,000
-3.4%
282,980
+17.6%
0.26%
-20.6%
Q1 2021$38,556,000
-3.9%
240,6710.0%0.32%
+0.9%
Q4 2020$40,141,000
-3.3%
240,671
-10.6%
0.32%
-18.5%
Q3 2020$41,523,000
+47.7%
269,079
+41.6%
0.39%
+31.3%
Q2 2020$28,114,000
+84.6%
190,079
+69.7%
0.30%
+75.7%
Q1 2020$15,232,000
-2.2%
112,0000.0%0.17%
+1.2%
Q4 2019$15,581,000
+72.1%
112,000
+19.1%
0.17%
+39.2%
Q3 2019$9,054,00094,0000.12%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q3 2022
NameSharesValueWeighting ↓
Vivo Capital, LLC 2,003,147$225,574,00020.44%
RA Capital Management 4,914,955$553,473,00017.48%
Sofinnova Investments, Inc. 1,109,874$124,983,00011.56%
Eversept Partners, LP 275,494$31,023,3797.71%
Avoro Capital Advisors LLC 1,787,000$201,234,0006.79%
Orbimed Advisors 3,287,400$370,194,0006.22%
Eventide Asset Management 1,698,648$191,285,0006.19%
Logos Global Management LP 120,000$13,513,0005.14%
Ghost Tree Capital, LLC 150,000$16,892,0004.48%
Spyglass Capital Management LLC 351,388$39,570,0004.47%
View complete list of ASCENDIS PHARMA A/S shareholders